Nucleic Acids Research, 2001, Vol. 29, No. 12 2558-2566
© 2001 Oxford University Press
A novel fluorometric oligonucleotide assay to measure O 6-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase
Department of Pharmacology and Toxicology, 1Department of Pediatrics and 2Department of Biochemistry and Molecular Biology, Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
DNA repair status plays a major role in mutagenesis, carcinogenesis and resistance to genotoxic agents. Because DNA repair processes involve multiple enzymatic steps, understanding cellular DNA repair status has required several assay procedures. We have developed a novel in vitro assay that allows quantitative measurement of alkylation repair via O6-methylguanine DNA methyltransferase (MGMT) and base excision repair (BER) involving methylpurine DNA glycosylase (MPG), human 8-oxoguanine DNA glycosylase (hOGG1) and yeast and human abasic endonuclease (APN1 and APE/ref-1, respectively) from a single cell extract. This approach involves preparation of cell extracts in a common buffer in which all of the DNA repair proteins are active and the use of fluorometrically labeled oligonucleotide substrates containing DNA lesions specific to each repair protein. This method enables methylation and BER capacities to be determined rapidly from a small amount of starting sample. In addition, the stability of the fluorometric oligonucleotides precludes the substrate variability caused by continual radiolabeling. In this report this technique was applied to human breast carcinoma MDA-MB231 cells overexpressing human MPG in order to assess whether up-regulation of the initial step in BER alters the activity of selected other BER (hOGG1 and APE/ref-1) or direct reversal (MGMT) repair activities.
* To whom correspondence should be addressed. Tel: +1 317 274 5202; Fax: +1 317 274 8046; Email: lcericks{at}iupui.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Nagane, K. Kobayashi, A. Ohnishi, S. Shimizu, and Y. Shiokawa Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Protein Expression in Patients with Recurrent Glioblastoma Treated with Temozolomide Jpn. J. Clin. Oncol., December 21, 2007; (2007) hym132v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Lee, S.-G. Jin, S. Cai, Y. Chen, G. P. Pfeifer, and T. R. O'Connor Repair of Methylation Damage in DNA and RNA by Mammalian AlkB Homologues J. Biol. Chem., November 25, 2005; 280(47): 39448 - 39459. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cai, Y. Xu, R. J. Cooper, M. J. Ferkowicz, J. R. Hartwell, K. E. Pollok, and M. R. Kelley Mitochondrial Targeting of Human O6-Methylguanine DNA Methyltransferase Protects against Cell Killing by Chemotherapeutic Alkylating Agents Cancer Res., April 15, 2005; 65(8): 3319 - 3327. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Georgakilas, P. V. Bennett, D. M. Wilson III, and B. M. Sutherland Processing of bistranded abasic DNA clusters in {gamma}-irradiated human hematopoietic cells Nucleic Acids Res., October 19, 2004; 32(18): 5609 - 5620. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rinne, D. Caldwell, and M. R. Kelley Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells Mol. Cancer Ther., August 1, 2004; 3(8): 955 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, M. Luo, and M. R. Kelley Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: Enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition Mol. Cancer Ther., June 1, 2004; 3(6): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, D. W. Ohannesian, and L. C. Erickson Hammerhead Ribozyme-Mediated Sensitization of Human Tumor Cells after Treatment with 1,3-Bis(2-chloroethyl)-1-nitrosourea J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 506 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. MOORE, W.-Y. HUANG, J. CHUNG, and R. B. HAYES Epidemiologic Considerations to Assess Altered DNA Methylation from Environmental Exposures in Cancer Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 181 - 196. [Abstract] [Full Text] [PDF] |
||||






